Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Bone ; 29(4): 393-402, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11595624

ABSTRACT

Oncogenic osteomalacia is a rare paraneoplastic syndrome that is characterized biochemically by hypophosphatemia and low plasma 1,25-dihydroxyvitamin D3, and clinically by osteomalacia, pseudofractures, bone pain, fatigue, and muscle weakness. We present a patient with a malignant schwannoma as the underlying cause of this disorder. A permanent cell line (HMS-97) derived from this tumor showed evidence of neuroendocrine differentiation by immunohistochemistry and of neurosecretory activity by electron microscopy. The cell line did express PHEX (phosphate-regulating gene with homologies to endopeptidases located on the X-chromosome) and FGF-23 (fibroblast growth factor-23) transcripts on northern hybridization; however, none of the known mutations from the related mendelian disorders of X-linked hypophosphatemic rickets or autosomal-dominant hypophosphatemic rickets could be detected. Tumor cell (HMS-97)-derived conditioned medium did not inhibit phosphate transport in a standard opossum kidney cell assay and in animal experiments. The medium also showed no PTH1- or PTH2-receptor-stimulating bioactivity. HMS-97 cells might be useful for further studies that aim to determine the genetic mechanism that leads to the observed PHEX and FGF-23 expression, both of which might have a direct role in the pathogenesis of oncogenic osteomalacia. In addition, these cells might be a useful tool for the investigation of neuroendocrine Schwann cell function and autoimmune peripheral nerve disease.


Subject(s)
Fibroblast Growth Factors/genetics , Neurilemmoma/complications , Neuroendocrine Tumors/complications , Osteomalacia/etiology , Proteins/genetics , Female , Fibroblast Growth Factor-23 , Gene Expression Regulation, Neoplastic , Humans , Magnetic Resonance Imaging , Middle Aged , Neurilemmoma/diagnostic imaging , Neurilemmoma/pathology , Neuroendocrine Tumors/diagnostic imaging , Neuroendocrine Tumors/pathology , Osteomalacia/diagnostic imaging , PHEX Phosphate Regulating Neutral Endopeptidase , RNA, Messenger/analysis , Radionuclide Imaging , Tumor Cells, Cultured
2.
Genes Chromosomes Cancer ; 3(5): 394-9, 1991 Sep.
Article in English | MEDLINE | ID: mdl-1797087

ABSTRACT

Chromosomal in situ suppression (CISS) hybridization was used to investigate the distribution of material of chromosomes 1 and 5 present in marker chromosomes of Namalva cells. The Namalva cell line, established from a Burkitt's lymphoma, exhibits a highly variable female karyotype with a large number of marker chromosomes. Libraries from sorted human chromosomes 1 and 5 were used to delineate material of these chromosomes present in the Namalva karyotype. We used the DAB/peroxidase reaction and reflection contrast microscopy for detection of biotinylated hybrid molecules. Identification of chromosomes was achieved by fluorescent R-banding after CISS hybridization, which allowed the assignment of hybridized regions to the particular marker chromosomes. After CISS hybridization with a chromosome I library, the normal chromosome I was labelled as well as a large marker MI and the long arm of marker M3. Using a chromosome 5 library it could be shown that the distal part of the long arm of one chromosome 5 was translocated to marker M2. The normal chromosome 5 was completely labelled. The present investigation demonstrates the advantage of combining CISS hybridization and banding for the identification of complex, rearranged tumor karyotypes.


Subject(s)
Burkitt Lymphoma/genetics , Chromosomes, Human, Pair 1 , Chromosomes, Human, Pair 5 , Cell Line , Chromosome Banding , DNA Probes , Gene Library , Genetic Markers , Humans , Karyotyping , Nucleic Acid Hybridization
SELECTION OF CITATIONS
SEARCH DETAIL
...